IP Library Granted Patent US 12,414,920
Granted Patent B2
US 12,414,920 · App. 17/566,226 · Granted Sep 16, 2025

Spray-dried blood products and methods of making same

Inventors: Thomas H. Fischer (Durham, NC); Joseph A DaCorta (Durham, NC); Michael Lawrence Galiger (Durham, NC)
Assignee: Velico Medical Inc.
A61K9/1688A61F13/00063A61K9/0026A61K35/16A61K35/19A61L15/40A61L26/0047A61L26/0057A61L26/0076A61F2013/00306A61F2013/00472A61F2013/00927
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,414,920
App. No.
17/566,226
Granted
Sep 16, 2025
Kind
B2
Abstract

The present invention is directed to a method of preparing dehydrated blood products, comprising the steps of: (a) providing a hydrated blood product; (b) spray-drying the hydrated blood product to produce a dehydrated blood product, as well as dehydrated blood products made by the method. The present invention is directed to a method of treating a patient suffering from a blood-related disorder, comprising the steps of: (a) rehydrating a therapeutic amount of the dehydrated blood products to produce a rehydrated therapeutic composition; and (b) administering the rehydrated therapeutic composition to the patient. The present invention is directed to a bandage or surgical aid comprising the dehydrated blood products described above.

Claims (18)

1. A method of preparing dehydrated plasma, comprising the steps of:

a) providing hydrated plasma; and

b) spray drying said hydrated plasma at a temperature of at least about 110° C. to produce dehydrated plasma wherein one or more coagulation factors are retained after drying.

2. The method of claim 1 , wherein said hydrated plasma is physically or chemically modified.

3. The method of claim 2 , wherein said modification is chemical fixation.

4. The method of claim 2 , wherein said modification comprises additional diagnostic or therapeutic reagents.

5. The method of claim 4 , wherein said diagnostic or therapeutic reagents are selected from the group consisting of imaging agents, concentration factors, performance enhancement drugs, antimicrobial and antiviral reagents, universal donor solutions, and combinations thereof.

6. The method of claim 1 , wherein the one or more coagulation factor include FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII, protein S, protein C, von Willebrand factor, or a combination thereof.

7. The method of claim 1 , wherein the step b) includes spray drying said hydrated plasma at a temperature between about 110° C. and about 140° C.

8. A method of preparing spray dried plasma, comprising the steps of:

a) providing hydrated plasma; and

b) spray drying said hydrated plasma by a spray dryer at a temperature of at least about 110° C., wherein when rehydrated, the spray dried plasma has one or more coagulation factor levels of concentration and activity that are essentially the same as said hydrated plasma.

9. The method of claim 8 , wherein the one or more coagulation factor include FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII, proteinS, protein C, von Willebrand factor, or a combination thereof.

10. A method of preparing dehydrated plasma, comprising the steps of:

a) providing hydrated plasma; and

b) spray drying said hydrated plasma at a temperature of at least about 110° C. to produce dehydrated plasma; wherein, when rehydrated, the dehydrated plasma has one or more coagulation factor levels that induce clot formation.

11. The method of claim 10 , wherein the one or more coagulation factor levels that induce clot formation include FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII, protein S, protein C, von Willebrand factor, or a combination thereof.

12. The method of claim 10 , wherein the step b) includes spray drying said hydrated plasma at a temperature between about 110° C. and about 140° C.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: DACORTA, JOSEPH A; FISCHER, THOMAS H; GALIGER, MICHAEL L
To: ENTEGRION, INC.
Reel/Frame 072096/0124 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2025
From: ENTEGRION, INC
To: VELICO MEDICAL, INC
Reel/Frame 072096/0228 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 29, 2022
From: ENTEGRION, INC.
To: VELICO MEDICAL, INC.
Reel/Frame 061250/0440 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2021
From: FISCHER, THOMAS H.; DACORTA, JOSEPH A.; GALIGER, MICHAEL L.
To: ENTEGRION, INC.
Reel/Frame 058510/0424 →